SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-15-004723
Filing Date
2015-08-14
Accepted
2015-08-14 16:29:54
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gff10q_081415.htm 10-Q 278526
2 EXHIBIT 31.1 exh_311.htm EX-31.1 6311
3 EXHIBIT 31.2 exh_312.htm EX-31.2 6327
4 EXHIBIT 32.1 exh_321.htm EX-32.1 4440
  Complete submission text file 0001171843-15-004723.txt   1650925

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE xbit-20150630.xml EX-101.INS 209934
6 XBRL SCHEMA FILE xbit-20150630.xsd EX-101.SCH 21133
7 XBRL CALCULATION FILE xbit-20150630_cal.xml EX-101.CAL 20258
8 XBRL DEFINITION FILE xbit-20150630_def.xml EX-101.DEF 114227
9 XBRL LABEL FILE xbit-20150630_lab.xml EX-101.LAB 155185
10 XBRL PRESENTATION FILE xbit-20150630_pre.xml EX-101.PRE 115370
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37347 | Film No.: 151056322
SIC: 2834 Pharmaceutical Preparations